T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$1.76B |
| 2 |
Eli Lilly
LLY
|
+$1.4B |
| 3 |
Bank of America
BAC
|
+$1.3B |
| 4 |
Tesla
TSLA
|
+$1.19B |
| 5 |
Wells Fargo
WFC
|
+$784M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$6.47B |
| 2 |
Amazon
AMZN
|
+$3.71B |
| 3 |
Yum! Brands
YUM
|
+$2.84B |
| 4 |
Salesforce
CRM
|
+$2.77B |
| 5 |
Fortive
FTV
|
+$2.41B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.06% |
| 2 | Healthcare | 18.72% |
| 3 | Consumer Discretionary | 14.62% |
| 4 | Financials | 10.36% |
| 5 | Communication Services | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
Legend Biotech
LEGN
$3.93B
| $26.8M | ﹤0.01% |
655,798
+88,643
| +16% | +$4.16M |
|
827
eBay
EBAY
$46.5B
| $26.6M | ﹤0.01% |
721,283
+53
| +0% | +$2.36K |
|
828
Church & Dwight Co
CHD
$24B
| $26.5M | ﹤0.01% |
371,408
-302
| -0.1% | -$26.1K |
|
829
Rocket Pharmaceuticals
RCKT
$367M
| $26.2M | ﹤0.01% |
1,639,643
+232,294
| +17% | +$3.62M |
|
830
BHP
BHP
$222B
| $26M | ﹤0.01% |
431,592
+37,557
| +10% | +$1.99M |
|
831
C4 Therapeutics
CCCC
$502M
| $26M | ﹤0.01% |
2,964,056
-1,419,107
| -32% | -$14.7M |
|
832
Mine Safety
MSA
$7.32B
| $25.9M | ﹤0.01% |
236,923
-941,642
| -80% | -$116M |
|
833
Pliant Therapeutics
PLRX
$66.9M
| $25.7M | ﹤0.01% |
+1,231,844
| New | +$23.6M |
|
834
Lennar Class A
LEN
$21.1B
| $25.6M | ﹤0.01% |
355,231
-2,544
| -0.7% | -$198K |
|
835
Valmont Industries
VMI
$9.5B
| $25.6M | ﹤0.01% |
95,417
-318,546
| -77% | -$84.2M |
|
836
Alignment Healthcare
ALHC
$2.79B
| $25.5M | ﹤0.01% |
2,154,645
-6,651,242
| -76% | -$97.1M |
|
837
Invitation Homes
INVH
$18B
| $25.5M | ﹤0.01% |
754,901
+388,208
| +106% | +$14.4M |
|
838
Ziff Davis
ZD
$1.92B
| $25.5M | ﹤0.01% |
372,185
-5,403
| -1% | -$425K |
|
839
CBIZ
CBZ
$2.96B
| $25.5M | ﹤0.01% |
595,580
+53,565
| +10% | +$2.34M |
|
840
Federal Realty Investment Trust
FRT
$10.3B
| $25.5M | ﹤0.01% |
282,457
-133,307
| -32% | -$13.5M |
|
841
Champion Homes
SKY
$5.23B
| $25.4M | ﹤0.01% |
481,196
-1,933,828
| -80% | -$113M |
|
842
McGrath RentCorp
MGRC
$2.94B
| $25.3M | ﹤0.01% |
301,753
-812,751
| -73% | -$67.5M |
|
843
Amcor
AMCR
$21.4B
| $25.3M | ﹤0.01% |
431,370
+21,761
| +5% | +$1.33M |
|
844
LyondellBasell Industries
LYB
$20.2B
| $25.2M | ﹤0.01% |
334,205
-2,023
| -0.6% | -$171K |
|
|
ENV
845
DELISTED
ENVESTNET, INC.
ENV
| $25.1M | ﹤0.01% |
565,988
-41,238
| -7% | -$2.2M |
|
846
Wabtec
WAB
$50.3B
| $24.9M | ﹤0.01% |
306,663
+50,426
| +20% | +$4.45M |
|
847
Regions Financial
RF
$27B
| $24.9M | ﹤0.01% |
1,238,542
+3,906
| +0.3% | +$82.5K |
|
848
Cirrus Logic
CRUS
$6.08B
| $24.8M | ﹤0.01% |
360,994
-8,205
| -2% | -$644K |
|
849
Hilton Grand Vacations
HGV
$3.49B
| $24.6M | ﹤0.01% |
748,755
+4,689
| +0.6% | +$187K |
|
850
Cogent Communications
CCOI
$530M
| $24.6M | ﹤0.01% |
471,673
-36,605
| -7% | -$2.11M |
|
Similar funds
T. Rowe Price Associates's Q3 2022 Portfolio in Review
As of Q3 2022, T. Rowe Price Associates held 3,114 positions worth $610B, down 23% from $791B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
T. Rowe Price Associates withdrew a net $168B in Q3 2022, closing 171 positions and reducing 1,248 holdings. Its most notable exit was Alcon, an estimated $1.51B position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, T. Rowe Price Associates opened a new position in Corebridge Financial worth $194M.
- T. Rowe Price Associates's largest Q3 2022 buy was Corebridge Financial: 9,831,688 shares worth $194M.
- T. Rowe Price Associates added most to ExxonMobil in Q3 2022, an estimated $1.76B increase.
- T. Rowe Price Associates's biggest Q3 2022 reduction was Microsoft, cutting an estimated $6.47B.
- T. Rowe Price Associates fully exited Alcon in Q3 2022, selling an estimated $1.51B.
- T. Rowe Price Associates's ten largest holdings make up 31% of its $610B portfolio in Q3 2022.
- T. Rowe Price Associates opened 154 new positions and closed 171 in Q3 2022.
- T. Rowe Price Associates's portfolio value fell 23% quarter-over-quarter to $610B.
Based on T. Rowe Price Associates's 13F filing for Q3 2022, filed 14 Nov 2022.